In deliveryUnited Kingdom
Meningitis B Vaccine (2026)
- Published
- Published 9 September 2025
Overview
UK Health Security Agency has awarded a contract to GlaxoSmithKline UK Limited on 21 May 2026 for the provision of meningococcal B vaccine for use in the national childhood immunisation programme and a targeted programme to protect at-risk adults against gonorrhoea. The contract is now in delivery. The actual contract value is withheld from publication to protect the supplier's commercial interests.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Procedure
- Direct
- Published
- 9 September 2025
Award outcome
- Awarded value
- £2
- Award date
- 21 May 2026
- Contract period
- 30 September 2026 → 30 September 2029
- GLAXOSMITHKLINE UK LIMITED
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
30 June 2026
View notice ↗Contract
22 May 2026
View notice ↗Contract
9 September 2025
View notice ↗
Contracting authority
UK Health Security Agency
BuyerLondon, United Kingdom
GB-NHS: U6N4T
Authority website ↗Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
BuyerLondon, United Kingdom
GB-PPON: PBMQ-7576-DVGW
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.